Consortium invests $30m in series-B round for Eyevensys
Boehringer Ingelheim Venture Fund has led a $30m series-B round for France-based Eyevensys, a clinical-stage biotechnology company developing non-viral gene therapies for retinal and other ophthalmic diseases.
More on Expansion
IK takes minority stake in EDH
Existing investors Quilvest Capital Partners and Amin Khiari retain stakes in the group
Dila Capital in €8m funding round for ByHours
Company plans to use the financing to boost its presence in Europe and Latin America, and expand in the US
Goldman Sachs, BPI France et al. back $70m round for LumApps
Latest fundraise for the France-based SaaS provider follows a $24m series-B in Q3 2019
Capnamic et al. back €11m series-A for Home
Round for rental and leasing app also saw participation from FJ Labs, EQT Ventures and Redalpine
Latest News
USS opens up DC section to PE investments
Move comes as funds invested in DC have exceeded £1bn, but exposure to private markets assets was already available to DB members
Nimbus acquires Dresselhaus
GP bought the fasteners and fixings manufacturer as part of a succession process for the company
IK takes minority stake in EDH
Existing investors Quilvest Capital Partners and Amin Khiari retain stakes in the group
HIG Capital-backed Cadica buys Scatolificio Giorgi
GP intends to pursue an intense aggregation strategy with further acquisitions across the sector